New ICU score could help doctors spot sicker patients faster

NCT ID NCT07338240

Recruiting now Knowledge-focused Sponsor: Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new scoring system called SOFA-2, which measures organ failure in critically ill patients in intensive care units (ICUs). Researchers will follow 5,200 adults in Turkish ICUs and calculate their scores using routine lab results and vital signs. The goal is to see if SOFA-2 predicts who will survive better than the current scoring method. No extra tests or treatments are given—this is purely an observation to improve how doctors assess severity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could give doctors a more accurate tool to assess how sick ICU patients are and predict their chances of survival.
What could go wrong: This is an observational study, not a treatment trial. The new score may not prove better than the existing one, and results may not apply outside Türkiye.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICALLY ILL INTENSIVE CARE UNIT PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICALLY ILL INTENSIVE CARE UNIT PATIENTS INTENSIVE CARE UNIT PATIENTS

Contacts and locations

Locations

University of Health Sciences Turkey, İzmir School of Medicine, Dr. Suat Seren Chest Disease and Thoracic Surgery Training and Research Hospital, Intensive Care Unit
RECRUITING

Izmir, İzmir, 35110, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.